Show simple item record

dc.contributor.authorWeinhold, N
dc.contributor.authorSalwender, HJ
dc.contributor.authorCairns, DA
dc.contributor.authorRaab, MS
dc.contributor.authorWaldron, G
dc.contributor.authorBlau, IW
dc.contributor.authorBertsch, U
dc.contributor.authorHielscher, T
dc.contributor.authorMorgan, GJ
dc.contributor.authorJauch, A
dc.contributor.authorDavies, FE
dc.contributor.authorHänel, M
dc.contributor.authorCook, G
dc.contributor.authorScheid, C
dc.contributor.authorHoulston, R
dc.contributor.authorGoldschmidt, H
dc.contributor.authorJackson, G
dc.contributor.authorKaiser, MF
dc.date.accessioned2021-08-12T09:03:37Z
dc.date.available2021-08-12T09:03:37Z
dc.date.issued2021-10-01
dc.identifier.citationHaematologica, 2021
dc.identifier.issn0390-6078
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4741
dc.identifier.eissn1592-8721
dc.identifier.doi10.3324/haematol.2021.278888
dc.description.abstractNot available.
dc.formatPrint-Electronic
dc.languageeng
dc.language.isoeng
dc.publisherFERRATA STORTI FOUNDATION
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0
dc.titleChromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients.
dc.typeJournal Article
dcterms.dateAccepted2021-06-03
rioxxterms.versionVoR
rioxxterms.versionofrecord10.3324/haematol.2021.278888
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0
rioxxterms.licenseref.startdate2021-06-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfHaematologica
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamCancer Genomics
icr.researchteamMyeloma Group
icr.researchteamCancer Genomics
icr.researchteamMyeloma Group
dc.contributor.icrauthorHoulston, Richard
dc.contributor.icrauthorKaiser, Martin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0